The increasing potential for commercial applications in biotechnology has given rise to new legal and ethical questions with regard to ownership of human tissue.
As the potential value of human cells and tissue has risen, so have donors' calls for a share in the profits.
However, in a recent California ruling (John Moore vs the Regents of the University of California), the court traditional position that individuals do not hold property rights in their own tissue and cells.
We will show that, in the rare case where tissue value may be determined prospectively, a one-time payment (and, hence granting a property right) is efficient.
Mots-clés Pascal : Biotechnologie, Législation, Ethique, Lignée cellulaire, Origine humaine, Donneur, Financement, Aspect juridique, Tissu, Droit propriété, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Biotechnology, Legislation, Ethics, Cell line, Human origin, Donor, Financing, Legal aspect, Tissue, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0341900
Code Inist : 002B30A09. Création : 199406.